• The Collaborative Cross

    UNC is the source of the "Collaborative Cross," a large panel of genetically engineered mouse strains that reflect the natural genomic diversity seen in humans and thus will enable researchers to better model complex diseases like cancer and diabetes.

    Learn more

  • HIV research

    UNC researchers are propelling the field of HIV research forward through unprecedented work toward a cure and proof of principle for “treatment as prevention,” recognized as the journal Science’s “Breakthrough of the Year” in 2011.

    Learn more

  • Hepatitis C research

    In a project funded by three industry sponsors, experts in biomedical informatics at UNC are creating a national database to perform a longitudinal observation study testing a triple-therapy regimen for hepatitis C infection.

    Learn more

  • Hunter syndrome (MPS II) research

    A UNC pediatrician developed the first and only treatment currently available for children with the rare genetic disease Hunter syndrome, using enzyme replacement therapy with a compound called idursulfase.

    Learn more

  • Nanoparticle drug delivery systems

    UNC scientists have precisely engineered nanocarriers for targeted delivery of vaccines and therapeutics to treat cancer and respiratory illnesses, now licensed through UNC startup companies Liquidia Technologies and Qualiber.

    Learn more

  • Duchenne muscular dystrophy treatment

    A molecular technique developed by researchers at UNC using strips of genetic code called antisense oligonucleotides to restore the function of a defective dystrophin gene is currently being tested in phase III clinical trials for patients with Duchenne muscular dystrophy.

    Learn more

  • Wound treatment

    Stasilon™, a glass-laced bandage created at UNC to drastically reduce blood loss from trauma or surgery, is currently approved for both military and civilian applications through UNC-CH startup Entegrion.

    Learn more

Partnering with UNC

The translation of cutting-edge research into outcomes that benefit the society is a core mission of UNC Chapel Hill that is advanced through promoting and fostering innovation and entrepreneurship throughout the university. Whether uncovering the fundamental mechanisms of disease or advancing new treatments and outcomes, our researchers stand ready to partner with industry. The close integration of our five nationally-ranked health sciences schools (Medicine, Public Health, Pharmacy, Dentistry, and Nursing) and comprehensive healthcare system gives UNC a powerful pathway for moving the results of biomedical research from laboratories to patient care settings.

Let's Get Started